Prospera Financial Services Inc Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Prospera Financial Services Inc grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 5.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,880 shares of the financial services provider’s stock after buying an additional 152 shares during the period. Prospera Financial Services Inc’s holdings in iShares Biotechnology ETF were worth $419,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. LMR Partners LLP acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth $4,904,000. Thrivent Financial for Lutherans raised its position in iShares Biotechnology ETF by 354.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 48,476 shares of the financial services provider’s stock worth $7,058,000 after buying an additional 37,814 shares during the last quarter. Evolution Wealth Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 3.3% in the 3rd quarter. Evolution Wealth Advisors LLC now owns 22,532 shares of the financial services provider’s stock worth $3,281,000 after acquiring an additional 710 shares during the period. Signature Estate & Investment Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 8.1% in the third quarter. Signature Estate & Investment Advisors LLC now owns 8,901 shares of the financial services provider’s stock valued at $1,296,000 after acquiring an additional 669 shares in the last quarter. Finally, OneDigital Investment Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 32.7% during the third quarter. OneDigital Investment Advisors LLC now owns 10,805 shares of the financial services provider’s stock worth $1,573,000 after acquiring an additional 2,661 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $137.96 on Monday. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57. The company has a 50-day moving average price of $143.43 and a 200 day moving average price of $141.87.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.